A locked nucleic acid antisense oligonucleotide (LNA) silences PCSK9 and enhances LDLR expression in vitro and in vivo.
The proprotein convertase subtilisin/kexin type 9 (PCSK9) is an important factor in the etiology of familial hypercholesterolemia (FH) and is also an attractive therapeutic target to reduce low density lipoprotein (LDL) cholesterol. PCSK9 accelerates the degradation of hepatic low density lipoprotei...
Main Authors: | Nidhi Gupta, Niels Fisker, Marie-Claude Asselin, Marie Lindholm, Christoph Rosenbohm, Henrik Ørum, Joacim Elmén, Nabil G Seidah, Ellen Marie Straarup |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-05-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2871785?pdf=render |
Similar Items
-
PCSK9 prosegment chimera as novel inhibitors of LDLR degradation.
by: Yascara Grisel Luna Saavedra, et al.
Published: (2013-01-01) -
Electronic Structures of LNA Phosphorothioate Oligonucleotides
by: Henrik G. Bohr, et al.
Published: (2017-09-01) -
Can Vitamin B12 Assist the Internalization of Antisense LNA Oligonucleotides into Bacteria?
by: Sara Souto Pereira, et al.
Published: (2021-04-01) -
Structure Activity Relationships of α-L-LNA Modified Phosphorothioate Gapmer Antisense Oligonucleotides in Animals
by: Punit P Seth, et al.
Published: (2012-01-01) -
Highly Potent GalNAc-Conjugated Tiny LNA Anti-miRNA-122 Antisense Oligonucleotides
by: Tsuyoshi Yamamoto, et al.
Published: (2021-05-01)